Safety and effectiveness of lurasidone in the treatment of Chinese schizophrenia patients: An interim analysis of post-marketing surveillance.

Authors:
Wei YM; Wang XJ; Yang XD; Wang CS; Wang LL and 6 more

Journal:
World J Psychiatry

Publication Year: 2023

DOI:
10.5498/wjp.v13.i11.937

PMCID:
PMC10701211

PMID:
38073894

Journal Information

Full Title: World J Psychiatry

Abbreviation: World J Psychiatry

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychiatry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict-of-interest statement: The authors declare no conflicts of interest."

Evidence found in paper:

"Supported by Collaborative Innovation Center Project of Translational Medicine, Shanghai Jiaotong University School of Medicine, No. TM202116PT (2021-2023); Clinical Research Plan of SHDC, No. SHDC2022CRS032; and the Sumitomo Pharmaceuticals (Suzhou) Co., Ltd."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025